World News Insights
1-3 Minute Gist

All Topics Article

Outlook Is Cut for U.S. Drug Sales

Wall Street Journal Original article ›

Keywords:

LyrArc Article Gist
Slowdown in drug sales growth in USA and Europe. Top seven emerging markets will account for 34% of global sales growth upfrom 7% in 2000. And the USA accounted for 40 to50% of growth in global pharmaceutical sales each year early in this decade, in 2009 the sales in the USA will account for just 9%. Forecasts and figures are from IMS consulting firm. USA sales will rise only 1-2% if at all, while emerging markets will grow by 4.5% to 5.5%. With the economic troubles American consumers are less likely to fill prescriptions and insurers are not covering new drugs and favoring generics. Intense competition among generics drug makers is reducing prices. IMS predicts that the global generic market will grow by 5 to 7% in 2009 to $68 billion, slowing from double digit growth. This is from total sales forecast for pharmaceuticals globally of $830 billion.

Pharmaceutical companies with Generics products are changing the marketplace.

07/26/2005

With growing demand for low cost affordable drugs the growth in sales of generics.

Grouped Articles

Indian Drug Maker Vies for Betapharm

Wall Street Journal 02/09/2006

Branded Drugs Settling More Generic Suits

Wall Street Journal 01/17/2006

Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain

Wall Street Journal 01/20/2006

As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future

Wall Street Journal 01/05/2006

Teva to Acquire Ivax, Another Maker of Generic Drugs

New York Times 07/26/2005

Heard on the Street

Wall Street Journal 07/26/2005

The shift in focus to growing markets for pharmaceuticals in developing countries.

05/29/2007

Western pharmaceutical companies are putting more emphasis on building sales in growing developing countries.

Grouped Articles

China Sentences Former Drug Regulator to Death

New York Times 05/29/2007

Glaxo's Garnier Is Taking the Heat

Wall Street Journal 07/09/2007

Prescription-Drug Sales Growth Is Expected to Slow

Wall Street Journal 11/01/2007

Glaxo Chief Charts New Growth Strategy

Wall Street Journal 06/10/2008

Outlook Is Cut for U.S. Drug Sales

Wall Street Journal 10/29/2008

Drug Firms Target Newly Rich Abroad

Wall Street Journal 11/05/2008


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us